Structure Therapeutics Inc. Sponsored ADR

GPCR Healthcare Biotechnology

EPS
−36.4%
Free cash flow
−119.2%

Quarter to June 2026, against a year earlier

20.33 1.25 +6.55%
Market cap
$1.4B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Current Ratio

+8 more quarters

14.15 24.81 26.16 20.75
Net Debt/EBITDA
10.41 (38.49) 15.84 11.05
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.90) (1.11) 0.19 (1.65)
Book value per Share
13.17 25.61 19.98 18.64
Free Cash Flow
(52.57) (65.91) 14.05 (120.07)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026